Skip to content
Go to InnovestGlobal.com
Our Mission
Our Culture
Press Releases
Financial Reports
Corporate Governance
Board of Directors
Management Team
Investor Resources
Stock Information
Events & Presentations
RSS Feeds
Contact
Go to InnovestGlobal.com
OTC Markets: IVST
$0.08
+0.0011 (1.45%)
August 03, 2020 10:50 PM
Our Mission
Our Culture
Press Releases
Financial Reports
Corporate Governance
Management Team
Board of Directors
Investor Resources
Stock Information
Events & Presentations
RSS Feeds
Contact Us
Press Releases
Innovest Global Announces First Quarter 2020 Earnings
July 6, 2020
Innovest Global Provides COVID-19 Operational Update
June 15, 2020
Innovest Global Announces Fiscal 2019 Operational Results
May 18, 2020
Innovest Global Provides Update on Acquisition Plans
May 11, 2020
Innovest Global Files Form 10 Registration Statement with the Securities and Exchange Commission
April 20, 2020
Innovest Global Summarizes Operational and Capital Markets Approach During COVID-19
March 23, 2020
Innovest Global Acquires 100% of StemVax Therapeutics
March 3, 2020
Innovest Global to Present at the LD Micro Virtual Investor Conference on March 4, 2020 at 3:40 p.m. ET
February 25, 2020
Innovest Global Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program
February 12, 2020
Innovest Global Announces Third Quarter 2019 Earnings
November 20, 2019
Innovest Global Expands Board of Directors and Makes Strategic Management Change
October 8, 2019
Innovest Global Announces Upcoming Conference Participation and Biotech Award
September 4, 2019
Innovest Global Appoints New Finance Leader and Sets Investor Conference Schedule
August 12, 2019
Innovest Global Announces Second Quarter 2019 Earnings
August 6, 2019
View Archived Press Releases
